MedTrace Logo

Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease

NCT07269704 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2026-04-03

No results posted yet for this study

Summary

The aims of the study are as follows:

1. Determine how the eye absorbs supplements taken orally.
2. Look for specific signs in the proteins and substances in the eyes of people with eye diseases who are also taking nutritional supplements.

Conditions

  • Eye Diseases

Interventions

DRUG

Calcium alpha-ketoglutarate

Participants took 2 g/day of calcium alpha-ketoglutarate orally, twice daily, for 7 days.

Sponsors & Collaborators

Principal Investigators

  • Vinit Mahajan, MD, PhD · Stanford University

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-15
Primary Completion
2025-06-10
Completion
2025-06-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07269704 on ClinicalTrials.gov